vs

Side-by-side financial comparison of Axsome Therapeutics, Inc. (AXSM) and GigaCloud Technology Inc (GCT). Click either name above to swap in a different company.

GigaCloud Technology Inc is the larger business by last-quarter revenue ($332.6M vs $196.0M, roughly 1.7× Axsome Therapeutics, Inc.). GigaCloud Technology Inc runs the higher net margin — 11.2% vs -14.6%, a 25.7% gap on every dollar of revenue. On growth, Axsome Therapeutics, Inc. posted the faster year-over-year revenue change (65.0% vs 9.7%). GigaCloud Technology Inc produced more free cash flow last quarter ($77.1M vs $-18.7M). Over the past eight quarters, Axsome Therapeutics, Inc.'s revenue compounded faster (61.7% CAGR vs 36.6%).

Jazz Pharmaceuticals plc is a global biopharmaceutical company with a focus on oncology and neuroscience. It was founded in 2003 in California, United States and is now headquartered in Dublin, Ireland.

GigaCloud Technology Inc. is an American e-commerce company that helps retailers buy and sell big and bulky, non-standardized items such as furniture, appliances, and fitness equipment. They own a business-to-business online marketplace and act as a middleman by handling sales, logistics and also delivery to end customers. GigaCloud is headquartered in El Monte, California, and is listed on the Nasdaq stock exchange since August 2022.

AXSM vs GCT — Head-to-Head

Bigger by revenue
GCT
GCT
1.7× larger
GCT
$332.6M
$196.0M
AXSM
Growing faster (revenue YoY)
AXSM
AXSM
+55.4% gap
AXSM
65.0%
9.7%
GCT
Higher net margin
GCT
GCT
25.7% more per $
GCT
11.2%
-14.6%
AXSM
More free cash flow
GCT
GCT
$95.8M more FCF
GCT
$77.1M
$-18.7M
AXSM
Faster 2-yr revenue CAGR
AXSM
AXSM
Annualised
AXSM
61.7%
36.6%
GCT

Income Statement — Q4 FY2025 vs Q3 FY2025

Metric
AXSM
AXSM
GCT
GCT
Revenue
$196.0M
$332.6M
Net Profit
$-28.6M
$37.2M
Gross Margin
23.2%
Operating Margin
-13.8%
12.2%
Net Margin
-14.6%
11.2%
Revenue YoY
65.0%
9.7%
Net Profit YoY
61.9%
-8.6%
EPS (diluted)
$-0.55
$0.99

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AXSM
AXSM
GCT
GCT
Q4 25
$196.0M
Q3 25
$171.0M
$332.6M
Q2 25
$150.0M
$322.6M
Q1 25
$121.5M
$271.9M
Q4 24
$118.8M
$295.8M
Q3 24
$104.8M
$303.3M
Q2 24
$87.2M
$310.9M
Q1 24
$75.0M
$251.1M
Net Profit
AXSM
AXSM
GCT
GCT
Q4 25
$-28.6M
Q3 25
$-47.2M
$37.2M
Q2 25
$-48.0M
$34.6M
Q1 25
$-59.4M
$27.1M
Q4 24
$-74.9M
$31.0M
Q3 24
$-64.6M
$40.7M
Q2 24
$-79.3M
$27.0M
Q1 24
$-68.4M
$27.2M
Gross Margin
AXSM
AXSM
GCT
GCT
Q4 25
Q3 25
23.2%
Q2 25
23.9%
Q1 25
23.4%
Q4 24
22.0%
Q3 24
25.5%
Q2 24
24.6%
Q1 24
26.5%
Operating Margin
AXSM
AXSM
GCT
GCT
Q4 25
-13.8%
Q3 25
-27.0%
12.2%
Q2 25
-24.5%
11.1%
Q1 25
-46.9%
10.4%
Q4 24
-61.1%
9.3%
Q3 24
-59.8%
13.4%
Q2 24
-89.5%
8.8%
Q1 24
-89.7%
13.9%
Net Margin
AXSM
AXSM
GCT
GCT
Q4 25
-14.6%
Q3 25
-27.6%
11.2%
Q2 25
-32.0%
10.7%
Q1 25
-48.9%
10.0%
Q4 24
-63.1%
10.5%
Q3 24
-61.7%
13.4%
Q2 24
-91.0%
8.7%
Q1 24
-91.1%
10.8%
EPS (diluted)
AXSM
AXSM
GCT
GCT
Q4 25
$-0.55
Q3 25
$-0.94
$0.99
Q2 25
$-0.97
$0.91
Q1 25
$-1.22
$0.68
Q4 24
$-1.54
$0.76
Q3 24
$-1.34
$0.98
Q2 24
$-1.67
$0.65
Q1 24
$-1.44
$0.66

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AXSM
AXSM
GCT
GCT
Cash + ST InvestmentsLiquidity on hand
$322.9M
$365.9M
Total DebtLower is stronger
Stockholders' EquityBook value
$88.3M
$457.3M
Total Assets
$689.8M
$1.1B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AXSM
AXSM
GCT
GCT
Q4 25
$322.9M
Q3 25
$325.3M
$365.9M
Q2 25
$303.0M
$303.0M
Q1 25
$300.9M
$286.8M
Q4 24
$315.4M
$302.4M
Q3 24
$327.3M
$259.8M
Q2 24
$315.7M
$207.8M
Q1 24
$331.4M
$195.3M
Stockholders' Equity
AXSM
AXSM
GCT
GCT
Q4 25
$88.3M
Q3 25
$73.7M
$457.3M
Q2 25
$73.1M
$431.4M
Q1 25
$53.2M
$412.9M
Q4 24
$57.0M
$405.2M
Q3 24
$92.9M
$400.4M
Q2 24
$102.9M
$358.4M
Q1 24
$144.0M
$317.8M
Total Assets
AXSM
AXSM
GCT
GCT
Q4 25
$689.8M
Q3 25
$669.3M
$1.1B
Q2 25
$639.8M
$1.1B
Q1 25
$596.7M
$1.1B
Q4 24
$568.5M
$1.1B
Q3 24
$561.5M
$1.1B
Q2 24
$548.2M
$1.1B
Q1 24
$545.7M
$977.6M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AXSM
AXSM
GCT
GCT
Operating Cash FlowLast quarter
$-18.7M
$78.3M
Free Cash FlowOCF − Capex
$-18.7M
$77.1M
FCF MarginFCF / Revenue
-9.6%
23.2%
Capex IntensityCapex / Revenue
0.0%
0.4%
Cash ConversionOCF / Net Profit
2.10×
TTM Free Cash FlowTrailing 4 quarters
$-93.9M
$188.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AXSM
AXSM
GCT
GCT
Q4 25
$-18.7M
Q3 25
$1.0M
$78.3M
Q2 25
$-32.4M
$38.6M
Q1 25
$-43.4M
$9.4M
Q4 24
$-26.2M
$68.4M
Q3 24
$-18.6M
$55.2M
Q2 24
$-30.1M
$19.1M
Q1 24
$-53.5M
$15.3M
Free Cash Flow
AXSM
AXSM
GCT
GCT
Q4 25
$-18.7M
Q3 25
$988.0K
$77.1M
Q2 25
$-32.4M
$37.0M
Q1 25
$-43.7M
$7.0M
Q4 24
$-26.2M
$66.9M
Q3 24
$-18.7M
$51.4M
Q2 24
$-30.2M
$12.9M
Q1 24
$-53.6M
$11.3M
FCF Margin
AXSM
AXSM
GCT
GCT
Q4 25
-9.6%
Q3 25
0.6%
23.2%
Q2 25
-21.6%
11.5%
Q1 25
-36.0%
2.6%
Q4 24
-22.1%
22.6%
Q3 24
-17.9%
16.9%
Q2 24
-34.6%
4.2%
Q1 24
-71.4%
4.5%
Capex Intensity
AXSM
AXSM
GCT
GCT
Q4 25
0.0%
Q3 25
0.0%
0.4%
Q2 25
0.0%
0.5%
Q1 25
0.3%
0.9%
Q4 24
0.0%
0.5%
Q3 24
0.1%
1.3%
Q2 24
0.1%
2.0%
Q1 24
0.1%
1.6%
Cash Conversion
AXSM
AXSM
GCT
GCT
Q4 25
Q3 25
2.10×
Q2 25
1.12×
Q1 25
0.35×
Q4 24
2.21×
Q3 24
1.36×
Q2 24
0.71×
Q1 24
0.56×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AXSM
AXSM

Segment breakdown not available.

GCT
GCT

Services$108.4M33%
Transferred Over Time$89.8M27%
Product Sales To B$50.1M15%
Last Mile Delivery Service$49.2M15%
Warehousing Service$14.2M4%
Ocean Transportation Service$9.0M3%
Platform Commission$4.9M1%
Drayage Service$3.2M1%

Related Comparisons